Trials / Completed
CompletedNCT00712439
Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Gabapentin Extended Release (G-ER) Tablets in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 147 (actual)
- Sponsor
- Depomed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether a new Gabapentin tablet, is safe and effective for the treatment of painful diabetic peripheral neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gabapentin Extended Release tablets | |
| DRUG | Placebo |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-11-01
- Completion
- 2006-12-01
- First posted
- 2008-07-10
- Last updated
- 2011-06-08
Source: ClinicalTrials.gov record NCT00712439. Inclusion in this directory is not an endorsement.